1h Free Analyst Time
The transdermal drug delivery market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 4.9% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.
The transdermal drug delivery market is segmented as below:
By Application
- Analgesics
- Neurological disorders
- Hormone replacement therapy
- Cardiovascular disorders
- Others
By Type
- Transdermal patches
- Transdermal semisolids
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the transdermal drug delivery market covers the following areas:
- Transdermal drug delivery market sizing
- Transdermal drug delivery market forecast
- Transdermal drug delivery market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global transdermal drug delivery market: 3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing interest in transdermal medicines.'
According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- Boehringer Ingelheim International GmbH
- Croda International Plc
- Hisamitsu Pharmaceutical Co. Inc.
- Johnson and Johnson
- Kindeva Drug Delivery L.P.
- Luye Pharma Group Ltd.
- Medherant Ltd.
- Novartis AG
- ProSolus Inc.
- Purdue Pharma LP
- Radius Health Inc.
- Rusan Pharma Ltd.
- Sparsha Pharma International Pvt. Ltd.
- Teikoku Seiyaku Co. Ltd.
- UCB SA
- Viatris Inc.
